Dr. Omar Abdel-Rahman, MD - Ain Shams University

Dr. Omar Abdel-Rahman

MD

Ain Shams University

Egypt

Dr. Omar Abdel-Rahman, MD - Ain Shams University

Dr. Omar Abdel-Rahman

MD

Introduction

Primary Affiliation: Ain Shams University - Egypt

Publications

25Publications

561Reads

-Profile Views

81PubMed Central Citations

Risk of selected gastrointestinal toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis.

Expert Rev Gastroenterol Hepatol 2015 12;9(11):1433-45. Epub 2015 Sep 12.

a 1 Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2015.1087847DOI Listing
August 2016
8 Reads
2 Citations
2.550 Impact Factor

Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis.

Future Oncol 2015 14;11(17):2471-84. Epub 2015 Aug 14.

Medical Microbiology & Immunology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.118DOI Listing
June 2016
47 Reads
8 Citations
2.480 Impact Factor

Proteinuria in Patients with Solid Tumors Treated with Ramucirumab: A Systematic Review and Meta-Analysis.

Chemotherapy 2014 18;60(5-6):325-33. Epub 2015 Aug 18.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000437253DOI Listing
April 2016
34 Reads
2 Citations
1.554 Impact Factor

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus: a comparative systematic review and meta-analysis.

Expert Rev Anticancer Ther 2015 20;15(7):847-58. Epub 2015 May 20.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1047350DOI Listing
April 2016
31 Reads
2 Citations
2.250 Impact Factor

Use of angiotensin-converting enzyme inhibitors in the prophylaxis of anthracycline or trastuzumab-related cardiac dysfunction: preclinical and clinical considerations.

Expert Rev Anticancer Ther 2015 26;15(7):829-37. Epub 2015 May 26.

Ain Shams University, Clinical oncology department, Faculty of medicine, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1047766DOI Listing
April 2016
7 Reads
1 Citation
2.250 Impact Factor

Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review.

Future Oncol 2015 ;11(12):1829-43

Medical Microbiology & Immunology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.33DOI Listing
March 2016
6 Reads
1 Citation
2.480 Impact Factor

Targeting FGF receptors in colorectal cancer: from bench side to bed side.

Future Oncol 2015 ;11(9):1373-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.38DOI Listing
February 2016
6 Reads
2 Citations
2.480 Impact Factor

Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors: a comparative meta-analysis.

Future Oncol 2015 ;11(7):1109-22

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.16DOI Listing
February 2016
43 Reads
2 Citations
2.480 Impact Factor

Immune checkpoints aberrations and gastric cancer; assessment of prognostic value and evaluation of therapeutic potentials.

Crit Rev Oncol Hematol 2016 Jan 10;97:65-71. Epub 2015 Aug 10.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.08.015DOI Listing
January 2016
2 Reads
7 Citations
4.030 Impact Factor

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis.

Expert Opin Drug Saf 2015 Oct 27;14(10):1495-506. Epub 2015 Aug 27.

a Ain Shams University, Clinical Oncology Department, Faculty of Medicine , Lotfy Elsayed Street, Cairo 11665, Egypt +20 33 028 656 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2015.1074677DOI Listing
October 2015
33 Reads
1 Citation
2.911 Impact Factor

Systemic therapy options for malignant pleural mesothelioma beyond first-line therapy: a systematic review.

Expert Rev Respir Med 2015 Oct 7;9(5):533-49. Epub 2015 Sep 7.

a Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17476348.2015.1083426DOI Listing
October 2015
30 Reads
1 Citation

Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers.

Ther Clin Risk Manag 2015 28;11:1123-32. Epub 2015 Jul 28.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/TCRM.S71045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524527PMC
August 2015
41 Reads
1 Citation
1.343 Impact Factor

Combination of transarterial chemoembolisation (TACE) plus antivirals for the management of hepatitis B-related hepatocellular carcinoma: A systematic review of the literature.

Arab J Gastroenterol 2015 Jun 22;16(2):40-5. Epub 2015 Apr 22.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajg.2015.03.003DOI Listing
June 2015
6 Reads

Risk of mucocutaneous toxicities in patients with solid tumors treated with lapatinib: a systematic review and meta-analysis.

Curr Med Res Opin 2015 May;31(5):975-86

Clinical Oncology Department, Faculty of Medicine, Ain Shams University , Cairo , Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2015.1020367DOI Listing
May 2015
15 Reads
2 Citations
2.653 Impact Factor

Risk of selected gastrointestinal toxicities in patients with advanced non-small cell lung cancer receiving erlotinib: a systematic review and meta-analysis.

Expert Rev Anticancer Ther 2015 Apr 9;15(4):465-75. Epub 2015 Feb 9.

Faculty of Medicine, Clinical Oncology Department, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1014035DOI Listing
April 2015
46 Reads
1 Citation
2.250 Impact Factor

Hedgehog pathway aberrations and gastric cancer; evaluation of prognostic impact and exploration of therapeutic potentials.

Tumour Biol 2015 Mar 14;36(3):1367-74. Epub 2015 Feb 14.

Clinical Oncology Department, Faculty of Medicine, Ain shams University, Cairo, Egypt,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-015-3216-6DOI Listing
March 2015
6 Reads
6 Citations
2.840 Impact Factor

Revisiting oxaliplatin-based regimens for advanced hepatocellular carcinoma.

Curr Oncol Rep 2014 ;16(8):394

Faculty of Medicine, Ain Shams University, Cairo, Egypt,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-014-0394-0DOI Listing
January 2015
15 Reads
3 Citations
2.891 Impact Factor

Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature.

Crit Rev Oncol Hematol 2014 Jul 7;91(1):1-8. Epub 2014 Jan 7.

Medical Microbiology and Immunology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2013.12.013DOI Listing
July 2014
34 Reads
14 Citations
4.030 Impact Factor

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.

Expert Rev Anticancer Ther 2014 Jun 26;14(6):751-60. Epub 2014 Mar 26.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.894465DOI Listing
June 2014
2 Reads
1 Citation
2.250 Impact Factor

Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma.

Med Oncol 2013 4;30(3):655. Epub 2013 Jul 4.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Lofty Elsayed Street, Abbaseya, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-013-0655-zDOI Listing
April 2014
50 Reads
9 Citations
2.060 Impact Factor

Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience.

J Egypt Natl Canc Inst 2014 Mar 16;26(1):9-13. Epub 2013 Sep 16.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Abbaseya Square, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jnci.2013.08.003DOI Listing
March 2014
28 Reads

Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside.

J Egypt Natl Canc Inst 2013 Dec 21;25(4):165-71. Epub 2013 Sep 21.

Clinical Oncology Department, Ain Shams University, Egypt. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jnci.2013.08.002DOI Listing
December 2013
7 Reads
5 Citations